Does ALOGLIPTIN Cause Poor venous access? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Poor venous access have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 0.8% of all adverse event reports for ALOGLIPTIN.
11
Reports of Poor venous access with ALOGLIPTIN
0.8%
of all ALOGLIPTIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Poor venous access From ALOGLIPTIN?
Of the 11 reports.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN Cause?
Pemphigoid (98)
Pancreatitis (66)
Diarrhoea (60)
Nausea (60)
Rash (55)
Hypoglycaemia (46)
Vomiting (44)
Pancreatitis acute (43)
Drug ineffective (42)
Pruritus (42)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which ALOGLIPTIN Alternatives Have Lower Poor venous access Risk?
ALOGLIPTIN vs ALOGLIPTIN\METFORMIN
ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN vs ALOSETRON
ALOGLIPTIN vs ALPELISIB
ALOGLIPTIN vs ALPHA.-LIPOIC ACID